Resveratrol protects rat striatal slices against anoxia-induced dopamine release

dc.contributor.buuauthorGürsoy, Murat
dc.contributor.buuauthorBüyükuysal, Rifat Levent
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Farmakoloji ve Klinik Farmakoloji Anabilim Dalı.tr_TR
dc.contributor.researcheridAAH-1657-2021tr_TR
dc.contributor.scopusid57197640824tr_TR
dc.contributor.scopusid6602686612tr_TR
dc.date.accessioned2024-04-01T11:05:40Z
dc.date.available2024-04-01T11:05:40Z
dc.date.issued2008-09
dc.description.abstractIncubation of rat striatal slices in anoxic medium caused significant alterations in dopamine (DA) and 3,4-dihydroxyphenylacetic acid (DOPAC) outputs; while DA release increased several times, 50% decline in DOPAC output was observed under this condition. Tissue ATP level, on the other hand, was decreased 40% by anoxia. Presence of resveratrol in the medium decreased anoxia-induced DA release in a concentration-dependent manner. Enhanced DA output, however, was declined slightly by epicatechine and catechine, and not altered significantly by morin hydrate and quercetin dehydrate which are other penolic compounds present in the red wine. In contrary to DA output, anoxia-induced decline in tissue ATP level was not ameliorated by resveratrol. In addition to anoxia, resveratrol, as observed with DA uptake blocker nomifensine, also reduced DA release stimulated by ouabain. Efficiencies of both resveratrol and nomifensine to attenuate ouabain-induced DA output, however, were closely dependent on ouabain concentration in the medium. These results indicate that some phenolic compounds, particularly resveratrol decrease anoxia-induced DA output and appear promising agents to improve the alterations occurred under anoxic-ischemic conditions.en_US
dc.identifier.citationGürsoy, M. ve Büyükuysal, R.L. (2008). "Resveratrol protects rat striatal slices against anoxia-induced dopamine release". Neurochemical Research, 33(9), 1838-1844.en_US
dc.identifier.endpage1844tr_TR
dc.identifier.issn0364-3190
dc.identifier.issn1573-6903
dc.identifier.issue9tr_TR
dc.identifier.pubmed18438711tr_TR
dc.identifier.scopus2-s2.0-48349113657tr_TR
dc.identifier.startpage1838tr_TR
dc.identifier.urihttps://doi.org/10.1007/s11064-008-9645-5
dc.identifier.urihttps://link.springer.com/article/10.1007/s11064-008-9645-5
dc.identifier.urihttps://hdl.handle.net/11452/40890
dc.identifier.volume33tr_TR
dc.identifier.wos000258064900022tr_TR
dc.indexed.pubmedPubMed
dc.indexed.scopusScopus
dc.indexed.wosSCIE
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.journalNeurochemical Researchen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAnoxiaen_US
dc.subjectDopamine releaseen_US
dc.subjectPhenolic compoundsen_US
dc.subjectResveratrolen_US
dc.subjectStriatal slicesen_US
dc.subjectNerve-terminal damageen_US
dc.subjectGlucose deprivationen_US
dc.subjectTrans-resveratrolen_US
dc.subjectCerebral-ischemiaen_US
dc.subjectHippocampal sliceen_US
dc.subjectNeuronal deathen_US
dc.subjectCell-deathen_US
dc.subjectBrainen_US
dc.subjectAciden_US
dc.subjectNeurotransmittersen_US
dc.subjectBiochemistry & molecular biologyen_US
dc.subjectNeurosciences & neurologyen_US
dc.subject.emtree3,4 dihydroxyphenylacetic aciden_US
dc.subject.emtreeAdenosine triphosphateen_US
dc.subject.emtreeCatechinen_US
dc.subject.emtreeDopamineen_US
dc.subject.emtreeEpicatechinen_US
dc.subject.emtreeNomifensineen_US
dc.subject.emtreeOuabainen_US
dc.subject.emtreePhenol derivativeen_US
dc.subject.emtreeResveratrolen_US
dc.subject.emtreeAnimal experimenten_US
dc.subject.emtreeAnimal modelen_US
dc.subject.emtreeAnimal tissueen_US
dc.subject.emtreeAnoxiaen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeBrain ischemiaen_US
dc.subject.emtreeConcentration responseen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeCorpus striatumen_US
dc.subject.emtreeDopamine releaseen_US
dc.subject.emtreeDopamine uptakeen_US
dc.subject.emtreeDrug efficacyen_US
dc.subject.emtreeDrug mechanismen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeNeuroprotectionen_US
dc.subject.emtreeHypoxemiaen_US
dc.subject.emtreeNonhumanen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreeRaten_US
dc.subject.emtreeRed wineen_US
dc.subject.mesh3,4-Dihydroxyphenylacetic Aciden_US
dc.subject.meshAdenosine triphosphateen_US
dc.subject.meshAnimalsen_US
dc.subject.meshAnoxiaen_US
dc.subject.meshAntioxidantsen_US
dc.subject.meshCorpus striatumen_US
dc.subject.meshDopamineen_US
dc.subject.meshDopamine uptake inhibitorsen_US
dc.subject.meshEnzyme inhibitorsen_US
dc.subject.meshFemaleen_US
dc.subject.meshMaleen_US
dc.subject.meshNomifensineen_US
dc.subject.meshOuabainen_US
dc.subject.meshRatsen_US
dc.subject.meshRats, wistaren_US
dc.subject.meshStilbenesen_US
dc.subject.otherRattusen_US
dc.subject.otherStrophanthus gratusen_US
dc.subject.scopusCommon Carotid Artery; Fluoro Jade; Gerbillinaeen_US
dc.subject.wosBiochemistry & molecular biologyen_US
dc.subject.wosNeurosciencesen_US
dc.titleResveratrol protects rat striatal slices against anoxia-induced dopamine releaseen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections